Related references
Note: Only part of the references are listed.Discovery of cyclic sulfonamide derivatives as potent inhibitors of SARS-CoV-2
Young Sup Shin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2021)
Discovery of Halogenated Benzothiadiazine Derivatives with Anticancer Activity**
Bader I. Huwaimel et al.
CHEMMEDCHEM (2021)
MYLK4 promotes tumor progression through the activation of epidermal growth factor receptor signaling in osteosarcoma
Mengkai Yang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
A Sweet Combination: Developing Saccharin and Acesulfame K Structures for Selectively Targeting the Tumor-Associated Carbonic Anhydrases IX and XII
Silvia Bua et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Design, synthesis and biological evaluation of novel benzothiadiazine derivatives as potent PI3Kδ-selective inhibitors for treating B-cell-mediated malignancies
Xiaodong Ma et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Endothelial RhoA GTPase is essential for in vitro endothelial functions but dispensable for physiological in vivo angiogenesis
Fatema Tuz Zahra et al.
SCIENTIFIC REPORTS (2019)
4-Hydroxy-3-nitro-5-ureido-benzenesulfonamides Selectively Target the Tumor-Associated Carbonic Anhydrase Isoforms IX and XII Showing Hypoxia-Enhanced Antiproliferative Profiles
Alessio Nocentini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Synthesis and Antineoplastic Evaluation of Mitochondrial Complex II (Succinate Dehydrogenase) Inhibitors Derived from Atpenin A5
Hezhen Wang et al.
CHEMMEDCHEM (2017)
Design, synthesis and activity of novel sorafenib analogues bearing chalcone unit
Min Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Antiangiogenic cancer treatment: The great discovery and greater complexity (Review)
Ewa Maj et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Antiangiogenic therapy in oncology: current status and future directions
Gordon C. Jayson et al.
LANCET (2016)
Antiangiogenic Effects of VH02, a Novel Urea Derivative: In Vitro and in Vivo Studies
Suwadee Phowichit et al.
MOLECULES (2016)
Design, Synthesis, Activity and Docking Study of Sorafenib Analogs Bearing Sulfonylurea Unit
Chunjiang Wu et al.
MOLECULES (2015)
ACK1/TNK2 tyrosine kinase: molecular signaling and evolving role in cancers
K. Mahajan et al.
ONCOGENE (2015)
Synthesis of novel 1,2-benzothiazine 1,1-dioxide-3-ethanone oxime N-aryl acetamide ether derivatives as potent anti-inflammatory agents and inhibitors of monocyte-to-macrophage transformation
Malla Reddy Gannarapu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Cyclic Secondary Sulfonamides: Unusually Good Inhibitors of Cancer-Related Carbonic Anhydrase Enzymes
Janina Moeker et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Angiogenesis and Angiogenic Tyrosine Kinase Receptor Expression in Pediatric Brain Tumors
Jozsef Virag et al.
PATHOLOGY & ONCOLOGY RESEARCH (2014)
Effect of C7 Modifications on Benzothiadiazine-1,1-dioxide Derivatives on Their Inhibitory Activity and Selectivity toward Aldose Reductase
Shuzhen Zhang et al.
CHEMMEDCHEM (2013)
Impact of the Nature of the Substituent at the 3-Position of 4H-1,2,4-Benzothiadiazine 1,1-Dioxides on Their Opening Activity toward ATP-Sensitive Potassium Channels
Bernard Pirotte et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Targeting EGFR and VEGF(R) pathway cross-talk in tumor survival and angiogenesis
Annette K. Larsen et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Protein kinase D2 is a crucial regulator of tumour cell-endothelial cell communication in gastrointestinal tumours
Ninel Azoitei et al.
GUT (2010)
Dominant Effect of Antiangiogenesis in Combination Therapy Involving Cyclophosphamide and Axitinib
Jie Ma et al.
CLINICAL CANCER RESEARCH (2009)
Roles for VEGF in the adult
Arindel S. R. Maharaj et al.
MICROVASCULAR RESEARCH (2007)
New 3-alkylamino-4H-thieno-1,2,4-thiadiazine 1,1-dioxide derivatives activate ATP-sensitive potassium channels of pancreatic beta cells
Flemming E. Nielsen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Protein kinase C-dependent protein kinase D activation modulates ERK signal pathway and endothelial cell proliferation by vascular endothelial growth factor
C Wong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
3-Alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides as ATP-sensitive potassium channel openers:: Effect of 6,7-disubstitution on potency and tissue selectivity
P de Tullio et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Toward tissue-selective pancreatic B-cells KATP channel openers belonging to 3-alkylamino-7-halo-4H-1,2,4-benzothiadiazine 1,1-dioxides
P de Tullio et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Antiangiogenic effect of KR-31372 by apoptosis via mediation of mitochondrial KATP channel opening and the phosphatase and tensin homolog deleted from chromosome 10 phosphorylation
KY Kim et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Cardiac myofibroblasts: a novel source of vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR
V Chintalgattu et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2003)
Effect on insulin release of compounds structurally related to the potassium-channel opener 7-chloro-3-isopropylamino-4H-1,2,4-benzothiadiazine 1,1-dioxide (BPDZ 73):: introduction of heteroatoms on the 3-alkylamino side chain of the benzothiadiazine 1,1-dioxide ring
S Boverie et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2001)
3-alkylamino-4H-pyrido[2,3-e]-1,2,4-thiadiazine 1,1-dioxides structurally related to diazoxide and pinacidil as potassium channel openers acting on vascular smooth muscle cells:: Design, synthesis, and pharmacological evaluation
B Pirotte et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
